S. 27 - Preserve Access to Affordable Generics Act
- Sponsor:
- Herb Kohl
- Summary:
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Status:
- The bill has passed through committee and has been put on a legislative calendar.
Preserve Access to Affordable Generics Act
S. 27 — 112th Congress (2011–2012)
- Summary
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
- Other Titles
- Preserve Access to Affordable Generics Act
- Preserve Access to Affordable Generics Act
- Sponsor
- Herb Kohl
- Co-Sponsors
- Subjects
- Commerce
- Administrative law and regulatory procedures
- Competition and antitrust
- Contracts and agency
- Federal Trade Commission (FTC)
- Intellectual property
- Marketing and advertising
- Prescription drugs
- Related Bills
- Major Actions
Introduced 1/25/2011 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 1/25/2011 1/25/2011 Read twice and referred to the Committee on the Judiciary. 1/25/2011 Sponsor introductory remarks on measure. Put on a legislative calendar 7/21/2011 Committee on the Judiciary. Ordered to be reported without amendment favorably. 7/22/2011 Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report. Put on a legislative calendar 7/22/2011 Placed on Senate Legislative Calendar under General Orders. Calendar No. 110. Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
supported this bill
Contributions data source: OpenSecrets.org